AVT, Inc.
CORONA, CA · CIK 0001431888 · Biotech · Private
Computational chemistry and machine learning platform for molecular modeling and drug discovery
avt.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $170K
- 6 Form D · Jan 2013
- 165 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820092010201120122013
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $25,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $145,000 | |
| Private capital raised | Form D · SEC | $1,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1742 | Gossamer Bio | — | $728M |
| 1743 | PHI OPTICS INC | — | $450K |
| 1744 | Iambic Therapeutics | — | $323M |
| 1745 | AVT, Inc. | — | $170K |
| 1746 | INFINIFLUIDICS INC | — | — |
| 1747 | Airway Therapeutics, LLC | — | $54M |
| 1748 | Quoin Pharmaceuticals, Ltd. | — | $164M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Shannon IllingworthDirector · Executive Officer
- Natalie RusselDirector · Executive Officer
- Natalie RussellDirector · Executive Officer
- Loretta VermetteDirector · Executive Officer
- Lorretta VermetteDirector
- Lorrette VermetteDirector
- James WinsorDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.